 |
Code of Federal Regulations (Last Updated: November 8, 2024) |
 |
Title 21 - Food and Drugs |
|
|
Chapter I - Food and Drug Administration, Department of Health and Human Services |
|
|
SubChapter C - Drugs: General |
|
|
Part 201 - Labeling |
|
|
Subpart G - Specific Labeling Requirements for Specific Drug Products |
| § 201.300 - Notice to manufacturers, packers, and distributors of glandular preparations. |
| § 201.301 - Notice to manufacturers, packers, and distributors of estrogenic hormone preparations. |
| § 201.302 - Notice to manufacturers, packers, and distributors of drugs for internal use which contain mineral oil. |
| § 201.303 - Labeling of drug preparations containing significant proportions of wintergreen oil. |
| § 201.304 - Tannic acid and barium enema preparations. |
| § 201.305 - Isoproterenol inhalation preparations (pressurized aerosols, nebulizers, powders) for human use; warnings. |
| § 201.306 - Potassium salt preparations intended for oral ingestion by man. |
| § 201.307 - Sodium phosphates; package size limitation, warnings, and directions for over-the-counter sale. |
| § 201.308 - Ipecac syrup; warnings and directions for use for over-the-counter sale. |
| § 201.309 - Acetophenetidin (phenacetin)-containing preparations; necessary warning statement. |
| § 201.310 - Phenindione; labeling of drug preparations intended for use by man. |
| § 201.311 - [Reserved] |
| § 201.312 - Magnesium sulfate heptahydrate; label declaration on drug products. |
| § 201.313 - Estradiol labeling. |
| § 201.314 - Labeling of drug preparations containing salicylates. |
| § 201.315 - Over-the-counter drugs for minor sore throats; suggested warning. |
| § 201.316 - Drugs with thyroid hormone activity for human use; required warning. |
| § 201.317 - Digitalis and related cardiotonic drugs for human use in oral dosage forms; required warning. |
| § 201.320 - Warning statements for drug products containing or manufactured with chlorofluorocarbons or other ozone-depleting substances. |
| § 201.322 - Over-the-counter drug products containing internal analgesic/antipyretic active ingredients; required alcohol warning. |
| § 201.323 - Aluminum in large and small volume parenterals used in total parenteral nutrition. |
| § 201.325 - Over-the-counter drugs for vaginal contraceptive and spermicide use containing nonoxynol 9 as the active ingredient; required warnings and labeling information. |
| § 201.326 - Over-the-counter drug products containing internal analgesic/antipyretic active ingredients; required warnings and other labeling. |
| § 201.327 - Over-the-counter sunscreen drug products; required labeling based on effectiveness testing. |
| § 201.328 - Labeling of medical gas containers. |